These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37839636)

  • 41. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling.
    Xie S; Li X; Yan J; Yu H; Chen S; Chen K
    Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
    Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z
    Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathway.
    Liu H; Wang M; Jin Z; Sun D; Zhu T; Liu X; Tan X; Shi G
    Biochem Biophys Res Commun; 2021 Dec; 582():77-85. PubMed ID: 34695754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice.
    Kong L; Zhou Y; Bu H; Lv T; Shi Y; Yang J
    J Exp Clin Cancer Res; 2016 Sep; 35(1):131. PubMed ID: 27589954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
    Xu X; Tan X; Tampe B; Nyamsuren G; Liu X; Maier LS; Sossalla S; Kalluri R; Zeisberg M; Hasenfuss G; Zeisberg EM
    Cardiovasc Res; 2015 Mar; 105(3):279-91. PubMed ID: 25616414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.
    Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu Z; You W; Qin J; Dai X; Shen H; Wang X; Wu J
    Cell Prolif; 2019 May; 52(3):e12581. PubMed ID: 30895661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
    Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
    Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Wu WR; Shi XD; Zhang FP; Zhu K; Zhang R; Yu XH; Qin YF; He SP; Fu HW; Zhang L; Zeng H; Zhu MS; Xu LB; Wong PP; Liu C
    Oncogene; 2022 Apr; 41(16):2340-2356. PubMed ID: 35256782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
    Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma.
    Vanderborght B; De Muynck K; Gijbels E; Lefere S; Scott CL; Guilliams M; Beschin A; Vinken M; Verhelst X; Geerts A; Van Vlierberghe H; Devisscher L
    Int J Cancer; 2023 Jun; 152(12):2615-2628. PubMed ID: 36912275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-449c-5p availability is antagonized by circ-NOTCH1 for MYC-induced NOTCH1 upregulation as well as tumor metastasis and stemness in gastric cancer.
    Zhao X; Zhong Q; Cheng X; Wang S; Wu R; Leng X; Shao L
    J Cell Biochem; 2020 Oct; 121(10):4052-4063. PubMed ID: 31943342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans.
    Wang H; Song X; Liao H; Wang P; Zhang Y; Che L; Zhang J; Zhou Y; Cigliano A; Ament C; Superville D; Ribback S; Reeves M; Pes GM; Liang B; Wu H; Evert M; Calvisi DF; Zeng Y; Chen X
    Hepatology; 2021 Jul; 74(1):248-263. PubMed ID: 33368437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
    J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.